NCT00239018

Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

A Prospective, Open-label, Multicenter, Follow-up Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 144 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: —

Summary

The objective of this extension study is to allow patients being treated with enteric-coated mycophenolate sodium (core study CERL080A2405FR01) to continue on the same treatment and to assess the long-term safety of EC-MPS

Conditions

• De Novo Kidney Transplantation

Interventions

Type	Name	Description
DRUG	Enteric-Coated Mycophenolate Sodium (EC-MPS)

Timeline

• Start date: 2003-04-01
• Primary completion: 2005-07-01
• Completion: 2005-07-01
• First posted: 2005-10-14
• Last updated: 2011-01-31